Todas las investigaciones
ReclutamientoOBSERVACIONAL

A ELN-Multicenter Study on Phenotypic Evolution and Clinical Outcomes

This study is an international research project examining two blood conditions: Polycythemia Vera and Thrombocythemia. Researchers are looking back at patient records to understand how these conditions develop and change over time. They are particularly interested in people who first had Thrombocythemia and later developed Polycythemia Vera. By carefully comparing these patients with others who had only one of the conditions, the study aims to uncover important patterns and insights. This research is important because it could help doctors better predict how these diseases might progress and potentially lead to improved ways of managing them in the future. It's a way of learning from past patient experiences to help those living with these conditions today and tomorrow.

De un vistazo

Estado
Reclutamiento
Patrocinador
FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS
Objetivo de inscripción
678
Inicio
01 Dec 2025
Estimación de finalización
31 Dic 2026

¿De qué trata este estudio?

This study is a big international research project focused on two types of blood conditions: Polycythemia Vera (PV) and Thrombocythemia (ET). Both conditions involve problems with the bone marrow, which is where your blood cells are made. Researchers want to understand more about how these diseases work and how they might change over time in different people.

Specifically, the study is looking at patient records from the past. It's divided into two main parts. The first part compares people who initially had ET and then, over time, developed PV. These patients are called 'cases.' They are then carefully matched with other patients who had ET but did not develop PV. This matching is done based on things like when they were diagnosed and their age, to make sure the comparison is fair. By looking at these two groups, researchers hope to find out what might be different about the 'cases' that led them to develop the second condition.

The second part of the study also looks at people with PV, but these are individuals who developed PV from the start, without having ET first. These patients are compared to the group who developed PV after having ET, again using careful matching. This helps the researchers understand if PV that develops from ET is different from PV that appears on its own. Ultimately, this research aims to help doctors understand the 'life story' of these conditions better, which could lead to better ways to diagnose, monitor, and treat patients in the future.

Puntos clave

  • This study is about understanding how Polycythemia Vera and Thrombocythemia develop.
  • It uses past patient medical records, so no new tests or treatments are involved.
  • Researchers are comparing different groups of patients with these conditions.
  • The goal is to improve understanding and future care for patients.
  • Your data would be kept confidential and used anonymously.
  • It's a 'look back' study, learning from previous patient experiences.

¿Quién puede ser elegible?

This study is looking back at records of adults aged 18 to 100 who have been diagnosed with certain blood conditions. The main group they are interested in are people who first had a condition called Thrombocythemia (ET) and then later developed Polycythemia Vera (PV).

To be included, your original ET diagnosis and later PV diagnosis must have met specific medical guidelines from 2022. Also, your PV diagnosis must have been made by the end of 2020. Another important factor is that for those who had ET first, they must have a specific gene change called JAK2V617F.

¿Podría este estudio ser adecuado para ti?

Responde estas preguntas rápidas para ver si puedes ser elegible. Esto es solo una guía: el equipo de investigación toma la decisión final.

  1. Were you diagnosed with Thrombocythemia (ET) first?
  2. Then, did you later develop Polycythemia Vera (PV)?
  3. Was your PV diagnosis made by December 31, 2020?
  4. Do your records show you have the JAK2V617F gene change?
  5. Are you between 18 and 100 years old?
Responde cada pregunta para ver tu resultado.

¿En qué consiste la participación?

This is a 'retrospective' study, meaning researchers are looking at existing patient medical records from the past. You wouldn't need to do anything extra, like take new medication, have extra appointments, or undergo additional tests. Your past medical information, which has already been collected as part of your regular care, would be reviewed by the research team. There are no direct visits, assessments, or follow-ups required from you for this study, and therefore no specific duration for your direct involvement.

Riesgos y beneficios potenciales

Since this study only involves reviewing existing medical records, there are no physical risks involved for you. Your personal information would be handled with strict confidentiality. The potential benefit is that the knowledge gained from studying past patient experiences could help doctors better understand how these conditions develop and improve care for future patients. You always have the right to withdraw your consent for your de-identified data to be used in the study, if you have given it.

Locations (24)

  • Mayo Clinic
    Código postal verificado
    Rochester, United States· Activo, no reclutando
  • University Hospital Halle
    Código postal verificado
    Halle, Germany· Aún no reclutando
  • Hannover Medical School
    Código postal verificado
    Hanóver, Alemania· Reclutamiento
  • University Clinic for Hematology, Oncology, Hemostaseology and Palliative Care Johannes Wesling Medical Center
    Código postal verificado
    Minden, Germany· Reclutamiento
  • Divisione Ematologia, Fondazione IRCCS Policlinico San Matteo
    Código postal verificado
    Pavía, Italia· Aún no reclutando
  • Divisione Ematologia, Ospedale San Bortolo
    Código postal verificado
    Vicenza, Italy· Reclutamiento
  • A.S.O. SS. Antonio e Biagio e C.Arrigo, SC Ematologia
    Código postal verificado
    Alessandria, Italy· Aún no reclutando
  • ASST Papa Giovanni XXIII, SC Ematologia
    Código postal verificado
    Bergamo, Italy· Reclutamiento
  • Policlinico S. Orsola - Malpighi
    Código postal verificado
    Bologna, Italy· Aún no reclutando
  • ASST-Spedali Civili
    Código postal verificado
    Brescia, Italy· Aún no reclutando
  • AOU Careggi, Divisione di Ematologia
    Código postal verificado
    Florence, Italy· Reclutamiento
  • ASST Grande Ospedale Metropolitano Niguarda, Divisione di Ematologia
    Código postal verificado
    Milan, Italy· Aún no reclutando

Preguntas comunes

What is Polycythemia Vera (PV)?

It's a rare blood disorder where your body makes too many red blood cells, which can make your blood thicker and increase your risk of blood clots.

What is Thrombocythemia (ET)?

It's a condition where your body makes too many platelets, which are tiny blood cells involved in clotting. This can lead to bleeding or clotting problems.

Will I have to take any new medicine if I take part?

No, this study only looks at existing medical records. You won't be asked to take new medicine or undergo new treatments.

How will my privacy be protected?

Researchers will keep your personal information private and follow strict rules to protect your confidentiality. Your name or other identifying details won't be shared.

Why is this research important?

By looking at past patient information, doctors hope to learn more about how these blood conditions change and progress. This could lead to better ways to help people living with them in the future.

Cómo obtener más información

TIZIANO BARBUI, MD

Siempre hable con su médico de cabecera o especialista antes de decidir participar en un estudio.

¿Interesado en participar?

Registra tu interés

Comparte tus detalles y el equipo de investigación para "A ELN-Multicenter Study on Phenotypic Evolution and Clinical…" se pondrá en contacto contigo si puedes ser elegible. Siempre habla con tu médico antes de aceptar participar.

Discusión

Discusión comunitaria

Impulsado por nuestro foro en community.patient.info. Por favor, sea respetuoso — esto no es un consejo médico.